The O'Neill family successfully utilized viral digital media to generate immediate, large-scale public donations, which directly funded the transition to the first human clinical trials. This model demonstrates how non-traditional fundraising can prove the market and scientific validity of a therapy to attract later-stage corporate partners like Ultragenyx.